Clinical Trial Update: PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating PHOX2B PC-CAR T cells for relapsed or refractory neuroblastoma, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• PHOX2B PC-CAR T Cells

Snippet

Sponsor: Stephan Grupp MD PhD | Conditions: Refractory Neuroblastoma, Relapsed Neuroblastoma | Phase 1 | Status: RECRUITING